Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan versus candesartan for glucose metabolism in chronic heart failure
2005-002109-22Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2005
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telmisartan and candesartan in chronic heart failure (CHF) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Difference in improvement of insulin sensitivity between treatment groups. Started Oct 2005; status: completed.
02
Drugs
telmisartancandesartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2005-002109-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002109-22.